Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.050
+0.020 (1.94%)
Feb 5, 2026, 2:17 PM EST - Market open

Cognition Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
93295961139-
Market Cap Growth
201.47%-50.97%-2.39%-56.29%--
Enterprise Value
5482715216-
Last Close Price
1.030.701.852.106.32-
PB Ratio
2.491.552.431.512.72-
P/TBV Ratio
2.551.552.431.512.72-
Debt / Equity Ratio
0.010.040.050.04--1.00
Quick Ratio
6.202.493.075.807.251.95
Current Ratio
6.452.653.376.117.502.13
Return on Equity (ROE)
-109.73%-157.19%-79.69%-46.76%-60.93%-
Return on Assets (ROA)
-78.99%-103.15%-74.08%-49.69%-53.95%-149.26%
Return on Capital Employed (ROCE)
-122.10%-282.70%-202.90%-102.20%-55.80%-449.90%
Earnings Yield
-30.05%-116.59%-43.40%-35.15%-8.41%-
FCF Yield
-31.71%-97.74%-27.20%-30.72%-2.63%-
Buyback Yield / Dilution
-70.13%-32.31%-27.03%-355.42%-921.60%-8.18%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q